Physicochemical Properties
| Molecular Formula | C5H7NAO3 |
| Molecular Weight | 138.10 |
| Exact Mass | 138.029 |
| CAS # | 3715-29-5 |
| Related CAS # | 3-Methyl-2-oxobutanoic acid;759-05-7;Sodium 3-methyl-2-oxobutanoate-13C4,d4;1185115-88-1;Sodium 3-methyl-2-oxobutanoate-13C2,d;1216972-87-0;Sodium 3-methyl-2-oxobutanoate-d hydrate;Sodium 3-methyl-2-oxobutanoate-13C4,d3;1215605-14-3;Sodium 3-methyl-2-oxobutanoate-13C,d4;1202865-40-4;Sodium 3-methyl-2-oxobutanoate-13C,d4-1;2483824-45-7;Sodium 3-methyl-2-oxobutanoate-13C5;1173018-24-0;3-Methyl-2-oxobutanoic acid-13C2;634908-42-2;Sodium 3-methyl-2-oxobutanoate-d7;2483831-46-3;Sodium 3-methyl-2-oxobutanoate-13C2,d4;1007477-29-3 |
| PubChem CID | 2724059 |
| Appearance | White to light brown solid powder |
| Boiling Point | 170.2ºC at 760 mmHg |
| Melting Point | 220-230 °C (dec.)(lit.) |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 9 |
| Complexity | 119 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | WIQBZDCJCRFGKA-UHFFFAOYSA-M |
| InChi Code | InChI=1S/C5H8O3.Na/c1-3(2)4(6)5(7)8;/h3H,1-2H3,(H,7,8);/q;+1/p-1 |
| Chemical Name | sodium;3-methyl-2-oxobutanoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Microbial Metabolite Human Endogenous Metabolite |
| ln Vitro | In Escherichia coli, alpha-ketoisovaleric acid, or sodium 3-methyl-2-oxobutanoate, is a precursor to pantothenic acid[1]. Alpha-ketoisovaleric acid, also known as sodium 3-methyl-2-oxobutanoate, increases alpha-ketoisocaproic acid and alpha-keto-beta-methyl-n-valeric acid. However, it also depletes the corresponding amino acids and results in an early decrease in ornithine and a late increase in plasma arginine[2]. |
| ln Vivo | In rats, convulsions are induced by sodium 3-methyl-2-oxobutanoate (alpha-ketoisovaleric acid) via GABAergic and glutamatergic mechanisms[3]. |
| References |
[1]. alpha-Ketoisovaleric acid, a precursor of pantothenic acid in Escherichia coli. J Bacteriol. 1953 Apr;65(4):388-93. [2]. Oral administration of alpha-ketoisovaleric acid or valine in humans: blood kinetics and biochemical effects. J Lab Clin Med. 1984 Apr;103(4):597-605. [3]. Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res. 2001 Mar 9;894(1):68-73. |
| Additional Infomation | Sodium-3-methyl-2-oxobutyrate is an oxo carboxylic acid. |
Solubility Data
| Solubility (In Vitro) | H2O: 125 mg/mL (905.14 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (724.11 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.2411 mL | 36.2056 mL | 72.4113 mL | |
| 5 mM | 1.4482 mL | 7.2411 mL | 14.4823 mL | |
| 10 mM | 0.7241 mL | 3.6206 mL | 7.2411 mL |